SINO BIOPH.SUBDIV.HD-,025
SINO BIOPH.SUBDIV.HD-,025/ KYG8167W1380 /
SMZ1
14/06/2024 14:50:56
|
Var.
-0.0015
|
Volume |
Denaro16:17:06 |
Lettera16:17:06 |
Capitalizzazione di mercato |
Dividend Y. |
Rapporto P/E |
0.3204EUR
|
-0.47%
|
31,350 Fatturato: 10,528.0050 |
0.3209Quantità in denaro: 3,120 |
0.3410Quantità in lettera: 3,120 |
6.11 bill.EUR |
- |
- |
Descrizione business
Sino Biopharmaceutical Limited, together with its subsidiaries, is a research and development driven pharmaceutical conglomerate in the Republic of China. Its business encompasses a fully integrated chain in pharmaceutical products which covers an array of R&D platforms, a line-up of intelligent production and a strong sales system. The Group's products have gained a competitive foothold in various therapeutic categories with promising potentials, comprising a variety of biopharmaceutical and chemical medicines for treating tumours, liver disease, cardio-cerebral diseases, analgesia, respiratory system diseases and orthopedic diseases. In order to enhance our sustainable competitiveness, the Group attaches great importance to R&D breakthroughs and is positioned as an industry leader in terms of R&D expenditures and product innovation.
Consiglio di amministrazione & Consiglio di sorveglianza
CEO |
Tse Eric SY |
Consiglio di amministrazione |
Li Chunling, Theresa Tse, Tse Hsin, Chen,Sean, Ben Toogood, Jin Song, George Orphanides |
Consiglio di sorveglianza |
Cheng Cheung Ling, Theresa Tse, Tse, Eric S Y, Tse Hsin, Tian Zhoushan, Li Mingqin, Lu Zhengfei, Li Dakui, Lu Hong, Zhang Lu Fu, LI Kwok Tung Donald |
Dati aziendali
Name: |
Sino Biopharmaceutical Ltd. |
Indirizzo: |
Rm 4109, Office Tower, Convention Plaza, 1 Harbour Road,Wanchai, Hong Kong |
Telefono: |
+852-2802-9886 |
Fax: |
+852-2880-0847 |
E-mail: |
info@sino-biopharm.com
|
Internet: |
www.sinobiopharm.com |
Industria: |
Biotechnology |
Settore: |
Biotechnology |
Sub settore: |
Biotechnology |
Fine dell'anno finanziario: |
31/12 |
Flottante libero: |
51.86% |
Data dell'IPO: |
08/12/2003 |
Rapporti con gli investitori
Name: |
- |
IR telefono: |
- |
IR Fax: |
- |
IR e-mail: |
-
|
Company calendar
CW 27 | 05/07/2024
Dividend Payment
|